Dongcheng Pharmaceutical: Jilin Changchun Nuclear Medicine Production Center put into operation.

Dongcheng Pharmaceutical Industry Announces that, recently, the company received a notification from its wholly-owned subsidiary, Nanjing Jiangyuan Andico Electronic Research and Development Co., Ltd., stating that it had received the "Production License for Radiopharmaceuticals" issued by the Jiangsu Provincial Drug Administration. This adds a new production center for nuclear medicine in Changchun, Jilin. After material review, it complies with regulatory requirements, and approval has been granted for the Jilin Changchun Nuclear Medicine Production Center to commence operations. The approval of this review signifies that Andico's Jilin Changchun Nuclear Medicine Production Center has met the requirements for production, and Andico will now have an additional nuclear medicine production center.